AD-35 is a neuroprotectant for treating Alzheimer’s diseases by significantly inhibiting the production and release of proinflammatory cytokines TNF-α and IL-1β. References: Li L, Xu S, Liu L, Feng R, Gong Y, Zhao X, Li J, Cai J, Feng N, Wang L, Wang X, Peng Y. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease. J Alzheimers Dis. 2017;56(4):1403-1417. doi: 10.3233/JAD-160587. PubMed PMID: 28157092.

纯度：≥98%

CAS：1531586-58-9